NASDAQ:NPCE NeuroPace Q3 2026 Earnings Report $12.76 +0.09 (+0.71%) Closing price 04:00 PM EasternExtended Trading$12.76 +0.01 (+0.04%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast NeuroPace EPS ResultsActual EPSN/AConsensus EPS -$0.11Beat/MissN/AOne Year Ago EPSN/ANeuroPace Revenue ResultsActual RevenueN/AExpected Revenue$27.14 millionBeat/MissN/AYoY Revenue GrowthN/ANeuroPace Announcement DetailsQuarterQ3 2026Date11/3/2026TimeAfter Market ClosesConference Call DateTuesday, November 3, 2026Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile NeuroPace Earnings HeadlinesCapsoVision (NASDAQ:CV) and NeuroPace (NASDAQ:NPCE) Financial ReviewOctober 2, 2026 | americanbankingnews.comKeyBanc Initiates NeuroPace at Overweight With $18 Price TargetSeptember 18, 2026 | marketscreener.comMDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 7 at 1:00 AM | Stansberry Research (Ad)NeuroPace to Participate in 2026 Cantor Global Healthcare ConferenceSeptember 1, 2026 | businesswire.comNeuroPace to Participate in Wells Fargo 21st Annual Healthcare ConferenceAugust 31, 2026 | businesswire.comNeuroPace, Inc. (NPCE) Q2 2026 Earnings Call TranscriptAugust 14, 2026 | seekingalpha.comSee More NeuroPace Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroPace? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroPace and other key companies, straight to your email. Email Address About NeuroPaceNeuroPace (NASDAQ:NPCE) is a medical device company focused on developing and commercializing therapies for people with drug-resistant epilepsy. The company’s principal product is the RNS System, an implantable responsive neurostimulation device designed to monitor brain activity, identify abnormal electrical patterns associated with seizures, and deliver targeted stimulation intended to help prevent or reduce seizures. The RNS System includes an implanted neurostimulator, leads placed in or on the brain, and external tools that support device programming, patient monitoring, and the collection of seizure-related data. NeuroPace also provides software and clinical support services intended to help physicians evaluate recorded brain activity and manage therapy over time. Founded in 1997 and headquartered in Mountain View, California, NeuroPace received U.S. Food and Drug Administration approval for the RNS System in 2013. The company primarily serves the U.S. market through relationships with neurologists, epilepsy centers, and other healthcare providers. Its technology is intended for patients whose focal-onset seizures have not been adequately controlled with antiseizure medications.View NeuroPace ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Skydance Just Became a Media Giant—With an $80 Billion Debt LoadPenguin Solutions Is Soaring as AI Memory Demand ExplodesWall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunLamb Weston’s Turnaround Is Starting to Look RealRPM International’s Dividend King Status Just Got StrongerAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the Stakes Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
